Goldman Sachs’s Unity Biotechnology UBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,066
Closed -$4K 6281
2022
Q3
$4K Buy
+1,066
New +$6.72K ﹤0.01% 6110
2022
Q2
Sell
-2,320
Closed -$26K 6730
2022
Q1
$26K Sell
2,320
-6,696
-74% -$75.1K ﹤0.01% 6378
2021
Q4
$132K Buy
9,016
+4,848
+116% +$106K ﹤0.01% 6049
2021
Q3
$125K Sell
4,168
-3,033
-42% -$107K ﹤0.01% 5872
2021
Q2
$334K Buy
7,201
+247
+4% +$11.9K ﹤0.01% 5457
2021
Q1
$418K Sell
6,954
-6,000
-46% -$409K ﹤0.01% 5247
2020
Q4
$679K Buy
12,954
+7,096
+121% +$342K ﹤0.01% 4440
2020
Q3
$203K Sell
5,858
-375
-6% -$23.7K ﹤0.01% 4908
2020
Q2
$541K Sell
6,233
-290
-4% -$21.5K ﹤0.01% 4342
2020
Q1
$379K Sell
6,523
-2,614
-29% -$165K ﹤0.01% 4376
2019
Q4
$659K Buy
9,137
+1,554
+20% +$110K ﹤0.01% 4350
2019
Q3
$463K Sell
7,583
-25,012
-77% -$1.77M ﹤0.01% 4486
2019
Q2
$3.1M Sell
32,595
-1,415
-4% -$120K ﹤0.01% 3222
2019
Q1
$2.76M Sell
34,010
-17,298
-34% -$1.96M ﹤0.01% 3394
2018
Q4
$8.34M Buy
51,308
+1,641
+3% +$218K ﹤0.01% 2473
2018
Q3
$8.09M Sell
49,667
-3,902
-7% -$642K ﹤0.01% 2613
2018
Q2
$8.07M Buy
+53,569
New +$7.83M ﹤0.01% 2579

Other funds holding UBX